Eton Pharmaceuticals, Inc. (ETON) vs GH Research PLC (GHRS)

A side-by-side comparison of Eton Pharmaceuticals, Inc. and GH Research PLC across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ETON vs GHRS

growth of $100 · dividends reinvested · last 5y
ETON +814.8% (+55.7%/yr)GHRS +15.2% (+2.9%/yr)ETON compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $10020222023202420252026$915$115
ETON GHRS

ETON vs GHRS: by the numbers

  • •ETON is the larger company ($1.50B vs $1.49B market cap).
  • •ETON is profitable (12.02% net margin) while GHRS runs a net loss (0.00%).

Metrics side by side

Valuation

MetricETONGHRS
P/E ratio142.15N/A
Forward P/E50.27N/A
P/S ratio14.18N/A
P/B ratio32.154.15
EV / EBITDA71.92N/A
FCF yield0.98%N/A

Profitability

MetricETONGHRS
Gross margin57.87%0.00%
Operating margin0.09%0.00%
Net margin12.02%0.00%
ROE27.24%-17.32%
ROIC20.41%-19.87%

Growth (annualized)

MetricETONGHRS
Revenue CAGR (5Y)47.98%N/A
Total return CAGR (5Y)63.04%0.52%

Frequently asked

Is ETON or GHRS more profitable?
ETON runs the higher net margin — ETON at 12.02% versus GHRS at 0.00%.
How have ETON and GHRS total returns compared?
Over the past 5 years, ETON delivered 63.04% and GHRS delivered 0.52% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.